[go: up one dir, main page]

WO2001058914A3 - Haplotypes du gene de l'interleukine 15 - Google Patents

Haplotypes du gene de l'interleukine 15 Download PDF

Info

Publication number
WO2001058914A3
WO2001058914A3 PCT/US2001/004130 US0104130W WO0158914A3 WO 2001058914 A3 WO2001058914 A3 WO 2001058914A3 US 0104130 W US0104130 W US 0104130W WO 0158914 A3 WO0158914 A3 WO 0158914A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
haplotypes
interleukin
polymorphisms
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/004130
Other languages
English (en)
Other versions
WO2001058914A2 (fr
Inventor
Alison E Anastasio
Anne Chew
R Rex Denton
Krishnan Nandabalan
J Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU2001239750A priority Critical patent/AU2001239750A1/en
Priority to PCT/US2001/025470 priority patent/WO2002063044A2/fr
Publication of WO2001058914A2 publication Critical patent/WO2001058914A2/fr
Publication of WO2001058914A3 publication Critical patent/WO2001058914A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des polynucléotides contenant un ou plusieurs des onze nouveaux polymorphismes mononucléotidiques dans le gène humain de l'interleukine 15 (IL 15). L'invention concerne également des compositions et des méthodes de détection d'un ou de plusieurs de ces polymorphismes. De plus, l'invention concerne divers génotypes et haplotypes du gène de IL 15 existant dans la population.
PCT/US2001/004130 2000-02-08 2001-02-08 Haplotypes du gene de l'interleukine 15 Ceased WO2001058914A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001239750A AU2001239750A1 (en) 2000-02-08 2001-02-08 Haplotypes of the interleukin 15 gene
PCT/US2001/025470 WO2002063044A2 (fr) 2001-02-08 2001-08-15 Haplotypes du gene il15

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18105900P 2000-02-08 2000-02-08
US60/181,059 2000-02-08

Publications (2)

Publication Number Publication Date
WO2001058914A2 WO2001058914A2 (fr) 2001-08-16
WO2001058914A3 true WO2001058914A3 (fr) 2002-03-21

Family

ID=22662727

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/004130 Ceased WO2001058914A2 (fr) 2000-02-08 2001-02-08 Haplotypes du gene de l'interleukine 15

Country Status (2)

Country Link
AU (1) AU2001239750A1 (fr)
WO (1) WO2001058914A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002063044A2 (fr) * 2001-02-08 2002-08-15 Genaissance Pharmaceuticals, Inc. Haplotypes du gene il15
WO2008049620A1 (fr) * 2006-10-25 2008-05-02 Hexal Gentech Forschungs Gmbh Composition semi-solide à libération contrôlée
PT3138397T (pt) * 2013-10-15 2019-03-26 Regeneron Pharma Animais il-15 humanizados

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 20 December 1996 (1996-12-20), KRAUSE ET AL.: "H. sapiens IL15 gene", XP002946162, Database accession no. X91233.1 *
KRAUSE ET AL.: "Genomic structure and chromosomal localization of the human interleukin 15 gene (IL-15)", CYTOKINE, vol. 8, no. 9, September 1996 (1996-09-01), pages 667 - 674, XP002946159 *

Also Published As

Publication number Publication date
WO2001058914A2 (fr) 2001-08-16
AU2001239750A1 (en) 2001-08-20

Similar Documents

Publication Publication Date Title
WO2001023410A3 (fr) Isogenes cibles a usage medicamenteux: polymorphismes dans le gene d'interleukine
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001058914A3 (fr) Haplotypes du gene de l'interleukine 15
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2001079228A3 (fr) Haplotypes du gene f12
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001011010A3 (fr) Isogenes cibles de medicaments : polymorphismes dans le gene de la sous-unite alpha du recepteur i de l'immunoglobuline e
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001083499A3 (fr) Haplotypes du gene de l'il8
WO2001077132A3 (fr) Haplotypes du gene il5
WO2001072965A3 (fr) Haplotypes du gene fkbp8
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2001077131A3 (fr) Haplotypes du gene bglap
WO2001079221A3 (fr) Haplotypes du gene il8rb
WO2001079232A3 (fr) Haplotypes du gene mpl
WO2001079217A3 (fr) Haplotypes du gene scya3
WO2001079223A3 (fr) Haplotypes du gene akr1b1
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2001079238A3 (fr) Haplotypes du gene mmp3
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2001072966A3 (fr) Haplotypes du gene pltp

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP